MX362709B - Microesferas de buprenorfina de fuerte carga de medicamento y su método de fabricación. - Google Patents
Microesferas de buprenorfina de fuerte carga de medicamento y su método de fabricación.Info
- Publication number
- MX362709B MX362709B MX2015012232A MX2015012232A MX362709B MX 362709 B MX362709 B MX 362709B MX 2015012232 A MX2015012232 A MX 2015012232A MX 2015012232 A MX2015012232 A MX 2015012232A MX 362709 B MX362709 B MX 362709B
- Authority
- MX
- Mexico
- Prior art keywords
- dispersed phase
- drug load
- high drug
- producing
- same
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 239000004005 microsphere Substances 0.000 title abstract 2
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 title 1
- 229960001736 buprenorphine Drugs 0.000 title 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- 239000004372 Polyvinyl alcohol Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- 238000004945 emulsification Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000007764 o/w emulsion Substances 0.000 abstract 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 229920002451 polyvinyl alcohol Polymers 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/837,181 US9393211B2 (en) | 2013-03-15 | 2013-03-15 | High drug load buprenorphine microspheres and method of producing same |
| PCT/US2014/027982 WO2014143839A1 (en) | 2013-03-15 | 2014-03-14 | High drug load buprenorphine microspheres and method of producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015012232A MX2015012232A (es) | 2015-12-01 |
| MX362709B true MX362709B (es) | 2019-02-05 |
Family
ID=51528078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015012232A MX362709B (es) | 2013-03-15 | 2014-03-14 | Microesferas de buprenorfina de fuerte carga de medicamento y su método de fabricación. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9393211B2 (enExample) |
| EP (1) | EP2968577B1 (enExample) |
| JP (1) | JP6678571B2 (enExample) |
| CN (1) | CN105377301B (enExample) |
| BR (1) | BR112015022985A2 (enExample) |
| CA (1) | CA2904432A1 (enExample) |
| ES (1) | ES2717942T3 (enExample) |
| MX (1) | MX362709B (enExample) |
| WO (1) | WO2014143839A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
| EP2152315B1 (en) | 2007-05-25 | 2016-01-06 | Indivior UK Limited | Sustained delivery formulations of risperidone compounds |
| US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
| GB2513060B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
| ES2837803T3 (es) | 2012-07-26 | 2021-07-01 | Camurus Ab | Formulaciones de opioides |
| AU2013294915C1 (en) | 2012-07-26 | 2019-11-21 | Camurus Ab | Opioid formulations |
| US9636308B2 (en) * | 2013-03-15 | 2017-05-02 | Oakwood Laboratories LLC | High drug load buprenorphine microspheres and method of producing same |
| GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
| US20170065579A1 (en) * | 2015-09-08 | 2017-03-09 | Andreas Voigt | Sustained Release Low Dose Formulations and Uses Thereof |
| CN105596298B (zh) * | 2015-12-18 | 2018-08-14 | 山东大学 | 一种包载丁丙诺啡的peg-plga缓释微球及其制备方法 |
| CA3015488A1 (en) * | 2016-02-23 | 2017-08-31 | Biodelivery Sciences International, Inc. | Sustained release buprenorphine microspheres (srbm) and methods of use thereof |
| PL3512518T3 (pl) | 2016-09-13 | 2023-03-27 | Alar Pharmaceuticals Inc. | Preparaty buprenorfiny o przedłużonym uwalnianiu |
| TWI838372B (zh) | 2018-05-11 | 2024-04-11 | 昱展新藥生技股份有限公司 | 丁基原啡因衍生物之長效注射劑型及結晶型 |
| CN115605187B (zh) * | 2020-02-26 | 2024-09-17 | 福多兹制药公司 | 载有孕激素药物的可注射控释制剂 |
| CA3210098A1 (en) | 2021-02-24 | 2022-09-01 | Oakwood Laboratories, Llc | Microsphere formulations comprising lurasidone and methods for making and using the same |
| CN114392384B (zh) * | 2021-12-24 | 2023-04-11 | 河南驼人医疗器械研究院有限公司 | 一种制备高载药量栓塞微球的方法及收集装置 |
| CN115317453A (zh) * | 2022-09-01 | 2022-11-11 | 广东嘉博制药有限公司 | 一种缓释微球制剂及其制备方法与用途 |
| EP4611729A1 (en) * | 2022-10-31 | 2025-09-10 | Oakwood Laboratories, LLC | Mixed release profile polymer microsphere formulations comprising octreotide and methods for making and using the same |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5026556A (en) | 1988-11-10 | 1991-06-25 | Norwich Eaton Pharmaceuticals, Inc. | Compositions for the transdermal delivery of pharmaceutical actives |
| CA2382577C (en) | 1999-08-27 | 2008-01-22 | Southern Research Institute | Injectable buprenorphine microparticle compositions and their use |
| EP1555023A3 (en) * | 1999-08-27 | 2005-09-28 | Southern Research Institute | Injectable buprenorphine microparticle compositions and their use |
| US7041320B1 (en) | 2002-05-31 | 2006-05-09 | Biotek, Inc. | High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence |
| US20050048115A1 (en) | 2003-08-27 | 2005-03-03 | Murty Mangena | Buprenorphine microspheres |
| TWI362947B (en) | 2007-03-08 | 2012-05-01 | Univ Kaohsiung Medical | Controlled release pharmaceutical composition and manufacture method thereof |
| US9161943B2 (en) | 2007-12-31 | 2015-10-20 | Industrial Technology Research Institute | Sustained release composition and manufacturing method thereof |
| KR101113044B1 (ko) * | 2008-08-29 | 2012-02-27 | 동국제약 주식회사 | 용매교류증발법에 의한 서방출성 미립구의 제조방법 |
| US20100086597A1 (en) | 2008-10-06 | 2010-04-08 | Oakwood Laboratories LLC | Microspheres for the sustained release of octreotide with a low initial burst |
| WO2011087496A1 (en) | 2010-01-13 | 2011-07-21 | Oakwood Laboratories LLC | Microspheres for the sustained release of octreotide without an initial time lag |
| GB2481018B (en) | 2010-06-08 | 2015-03-18 | Rb Pharmaceuticals Ltd | Injectable flowable composition comprising buprenorphine |
-
2013
- 2013-03-15 US US13/837,181 patent/US9393211B2/en active Active
-
2014
- 2014-03-14 BR BR112015022985A patent/BR112015022985A2/pt not_active IP Right Cessation
- 2014-03-14 CA CA2904432A patent/CA2904432A1/en not_active Abandoned
- 2014-03-14 WO PCT/US2014/027982 patent/WO2014143839A1/en not_active Ceased
- 2014-03-14 JP JP2016502675A patent/JP6678571B2/ja active Active
- 2014-03-14 ES ES14764439T patent/ES2717942T3/es active Active
- 2014-03-14 CN CN201480021351.9A patent/CN105377301B/zh active Active
- 2014-03-14 MX MX2015012232A patent/MX362709B/es active IP Right Grant
- 2014-03-14 EP EP14764439.7A patent/EP2968577B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2904432A1 (en) | 2014-09-18 |
| JP6678571B2 (ja) | 2020-04-08 |
| US9393211B2 (en) | 2016-07-19 |
| JP2016513721A (ja) | 2016-05-16 |
| MX2015012232A (es) | 2015-12-01 |
| CN105377301B (zh) | 2020-06-05 |
| CN105377301A (zh) | 2016-03-02 |
| EP2968577A1 (en) | 2016-01-20 |
| EP2968577A4 (en) | 2016-11-23 |
| US20140271869A1 (en) | 2014-09-18 |
| BR112015022985A2 (pt) | 2017-08-22 |
| ES2717942T3 (es) | 2019-06-26 |
| WO2014143839A1 (en) | 2014-09-18 |
| EP2968577B1 (en) | 2019-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015012232A (es) | Microesferas de buprenorfina de fuerte carga de medicamento y su metodo de fabricacion. | |
| HRP20250181T1 (hr) | Spojevi i postupci za ciljanu razgradnju receptora androgena | |
| UY35298A (es) | Formulación en dispersión sólida de un compuesto antiviral | |
| AR095160A1 (es) | Formulaciones farmacéuticas a prueba de alteraciones | |
| CO7240372A2 (es) | Formulaciones farmacéuticas tópicas no acuosas | |
| BR112015023658A2 (pt) | formulação de vitamina d de liberação modificada, estabilizada e método de administração desta | |
| EA201690810A1 (ru) | Мягкие пастилки, содержащие экстракт куркумы | |
| CU24486B1 (es) | Dispersión sólida amorfa que comprende taxano, tabletas comprendiendo la misma y método para prepararla | |
| MX2015002300A (es) | Nanoparticulas polimericas de finasterida y minoxidil, metodo para preparar las mismas, suspension acuosa que contiene las mismas, composicion farmaceutica y su uso. | |
| CR20160438A (es) | Dispersión sólida amorfa que comprende taxano, comprimido que comprende la misma, y método para su preparación | |
| MX2016004444A (es) | Microparticulas que comprenden gnrh hechas mediante pgss. | |
| CO6351710A2 (es) | Composicion topica para el tratamiento de queratosis actinica | |
| UY35301A (es) | Formulación en dispersión sólida de un compuesto antiviral | |
| MX389333B (es) | Formulacion de buprenorfina inyectable. | |
| AU2016204395A1 (en) | Microspheres including oxidized cellulose | |
| AR093402A1 (es) | Producto de comicronizacion que comprende acetato de ulipristal | |
| CL2014002896A1 (es) | Una formulacion farmaceutica en la forma de una tableta recubierta que consiste de a) un nucleo obtenido a partir de una co-mezcla de manitol, croscarmelosa de sodio y al menos un compuestos activo, y b) un recubrimiento el cual se aplica en la forma de una solucion acuosa o que contiene agua y alcohol, y donde la tableta se desintegra rapidamente en presencia de humedad; y su proceso de preparacion. | |
| PH12016502536B1 (en) | Composite preparation comprising 5-a-reductase inhibitor-containing film coating layer, and method for producing the composite preparation | |
| MX2015012231A (es) | Microesferas de liberacion sostenida y metodo para producir las mismas. | |
| PH12017502149A1 (en) | Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester | |
| LT2964199T (lt) | Sausos farmacinės kompozicijos, apimančios aktyvaus agento nanodaleles, prisirišusias prie nešiklio dalelių | |
| MX2018010194A (es) | Microsferas de buprenorfina de liberacion sostenida (srbm) y metodos de uso de las mismas. | |
| ES2494620A1 (es) | Proceso integrado de obtención de alcoholes monoinsaturados, biodiesel y productos biodegradables a partir de aceite de Jojoba | |
| WO2012029076A3 (en) | Stable pharmaceutical composition | |
| MX2015017198A (es) | Matriz. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |